Panto Tad (Pantoprazole)

Pantoprazole blocks the H+/K+‑ATPase enzyme, commonly called the gastric proton pump, on the surface of stomach parietal cells. By inhibiting this final step of acid secretion, it produces a sustained increase in gastric pH, reducing the amount of acid that can damage the oesophagus and ulcer sites.

The dose of pantoprazole is determined by the prescribing clinician based on the specific indication, severity of disease and patient factors. Healthcare professionals set the appropriate strength and dosing schedule, which may differ for short‑term ulcer healing versus long‑term maintenance therapy.

Pantoprazole is classified as pregnancy category B in the EU, indicating no evidence of risk in animal studies but limited human data. It should be used only if the potential benefit justifies the potential risk to the fetus. Limited amounts are excreted in breast milk, so breastfeeding mothers should consult their physician before use.

To request Panto Tad, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Pantoprazole belongs to the proton pump inhibitor class, which provides more potent and longer‑lasting acid suppression than H2‑receptor antagonists such as ranitidine. Compared with other PPIs, pantoprazole has a low potential for CYP‑mediated drug interactions, making it a suitable option for patients on multiple medications.

Store Panto Tad tablets at ambient temperature, below 25 °C, in the original packaging. Protect the product from moisture, excessive heat and direct sunlight to maintain stability and potency throughout its shelf life.

Panto Tad tablets are taken orally, usually with water. They can be swallowed with or without food, although taking the tablet before a meal may improve absorption. Patients should follow the prescribing clinician’s instructions regarding timing and duration of therapy.

Serious but uncommon risks include severe allergic reactions (anaphylaxis), Clostridioides difficile‑associated diarrhoea, low magnesium levels, bone fractures with long‑term use, liver enzyme elevations and acute interstitial nephritis. Any signs of these conditions warrant immediate medical attention.

Pantoprazole is contraindicated in patients with known hypersensitivity to the drug or any other proton pump inhibitor. Caution is also advised for individuals with severe liver disease, those taking certain interacting medications such as clopidogrel, and patients who have had previous allergic reactions to similar agents.